These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67. [Development of an Inhalation Dry Powder Preparation Method without Heat-drying Process]. Ito T Yakugaku Zasshi; 2023; 143(4):353-358. PubMed ID: 37005236 [TBL] [Abstract][Full Text] [Related]
68. Particle engineering principles and technologies for pharmaceutical biologics. Cun D; Zhang C; Bera H; Yang M Adv Drug Deliv Rev; 2021 Jul; 174():140-167. PubMed ID: 33845039 [TBL] [Abstract][Full Text] [Related]
69. Suitability of differently formulated dry powder Newcastle disease vaccines for mass vaccination of poultry. Huyge K; Van Reeth K; De Beer T; Landman WJ; van Eck JH; Remon JP; Vervaet C Eur J Pharm Biopharm; 2012 Apr; 80(3):649-56. PubMed ID: 22155763 [TBL] [Abstract][Full Text] [Related]
70. Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation. Zhou QT; Morton DA; Yu HH; Jacob J; Wang J; Li J; Chan HK J Pharm Sci; 2013 Oct; 102(10):3736-47. PubMed ID: 23904207 [TBL] [Abstract][Full Text] [Related]
71. Bacteriophage Encapsulation Using Spray Drying for Phage Therapy. Malik DJ Curr Issues Mol Biol; 2021; 40():303-316. PubMed ID: 32678066 [TBL] [Abstract][Full Text] [Related]
72. Effect of thermal and shear stresses in the spray drying process on the stability of siRNA dry powders. Wu J; Wu L; Wan F; Rantanen J; Cun D; Yang M Int J Pharm; 2019 Jul; 566():32-39. PubMed ID: 31077763 [TBL] [Abstract][Full Text] [Related]
73. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols. Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131 [TBL] [Abstract][Full Text] [Related]
74. Advances in device and formulation technologies for pulmonary drug delivery. Chan JG; Wong J; Zhou QT; Leung SS; Chan HK AAPS PharmSciTech; 2014 Aug; 15(4):882-97. PubMed ID: 24728868 [TBL] [Abstract][Full Text] [Related]
75. A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics. Chan JG; Chan HK; Prestidge CA; Denman JA; Young PM; Traini D Eur J Pharm Biopharm; 2013 Feb; 83(2):285-92. PubMed ID: 22982733 [TBL] [Abstract][Full Text] [Related]
76. Overcoming challenges for development of amorphous powders for inhalation. Chang RYK; Chen L; Chen D; Chan HK Expert Opin Drug Deliv; 2020 Nov; 17(11):1583-1595. PubMed ID: 32811193 [TBL] [Abstract][Full Text] [Related]
77. Capreomycin inhalable powders prepared with an innovative spray-drying technique. Schoubben A; Giovagnoli S; Tiralti MC; Blasi P; Ricci M Int J Pharm; 2014 Jul; 469(1):132-9. PubMed ID: 24747443 [TBL] [Abstract][Full Text] [Related]
78. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders. Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252 [TBL] [Abstract][Full Text] [Related]
79. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols. Meenach SA; Vogt FG; Anderson KW; Hilt JZ; McGarry RC; Mansour HM Int J Nanomedicine; 2013; 8():275-93. PubMed ID: 23355776 [TBL] [Abstract][Full Text] [Related]
80. Advances in the development of antimicrobial peptides and proteins for inhaled therapy. Wang Y; Chang RYK; Britton WJ; Chan HK Adv Drug Deliv Rev; 2022 Jan; 180():114066. PubMed ID: 34813794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]